Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
Tuberculosis (Edinb) ; 116: 44-55, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-31153518

RESUMEN

Low molecular weight (LMW) thiols are molecules with a functional sulfhydryl group that enable them to detoxify reactive oxygen species, reactive nitrogen species and other free radicals. Their roles range from their ability to modulate the immune system to their ability to prevent damage of biological molecules such as DNA and proteins by protecting against oxidative, nitrosative and acidic stress. LMW thiols are synthesized and found in both eukaryotes and prokaryotes. Due to their beneficial role to both eukaryotes and prokaryotes, their specific functions need to be elucidated, most especially in pathogenic prokaryotes such as Mycobacterium tuberculosis (M.tb), in order to provide a rationale for targeting their biosynthesis for drug development. Ergothioneine (ERG), mycothiol (MSH) and gamma-glutamylcysteine (GGC) are LMW thiols that have been shown to interplay to protect M.tb against cellular stress. Though ERG, MSH and GGC seem to have overlapping functions, studies are gradually revealing their unique physiological roles. Understanding their unique physiological role during the course of tuberculosis (TB) infection, would pave the way for the development of drugs that target their biosynthetic pathway. This review identifies the knowledge gap in the unique physiological roles of LMW thiols and proposes their mechanistic roles based on previous studies. In addition, it gives an update on identified inhibitors of their biosynthetic enzymes.


Asunto(s)
Mycobacterium tuberculosis/metabolismo , Compuestos de Sulfhidrilo/metabolismo , Tuberculosis/microbiología , Animales , Antituberculosos/uso terapéutico , Cisteína/metabolismo , Dipéptidos/metabolismo , Inhibidores Enzimáticos/uso terapéutico , Enzimas/metabolismo , Ergotioneína/metabolismo , Glicopéptidos/metabolismo , Humanos , Inositol/metabolismo , Terapia Molecular Dirigida , Peso Molecular , Mycobacterium tuberculosis/efectos de los fármacos , Mycobacterium tuberculosis/patogenicidad , Tuberculosis/tratamiento farmacológico
2.
Sci Data ; 5: 180184, 2018 09 25.
Artículo en Inglés | MEDLINE | ID: mdl-30251996

RESUMEN

Mycothiol (MSH) and ergothioneine (ERG) are thiols able to compensate for each other to protect mycobacteria against oxidative stress. Gamma-glutamylcysteine (GGC), another thiol and an intermediate in ERG biosynthesis has detoxification abilities. Five enzymes are involved in ERG biosynthesis, namely EgtA, EgtB, EgtC, EgtD and EgtE. The role of these enzymes in the production of ERG had been unclear. On the other hand, the enzyme MshA is known to be essential for MSH biosynthesis. In this manuscript, we describe the raw data of the generation and characterization of Mycobacterium tuberculosis (M.tb) mutants harbouring a deletion of the gene coding for each of these enzymes, and the raw data of the phenotypic characterization of the obtained thiol-deficient M.tb mutants. High throughput screening (HTS) of off-patent drugs and natural compounds revealed few compounds that displayed a higher activity against the thiol-deficient mutants relative to the wild-type strain. The mode of action of these drugs was further investigated. Raw data displaying these results are described here.


Asunto(s)
Cisteína/deficiencia , Cisteína/genética , Dipéptidos/deficiencia , Dipéptidos/genética , Ergotioneína/deficiencia , Ergotioneína/genética , Glicopéptidos/deficiencia , Glicopéptidos/genética , Inositol/deficiencia , Inositol/genética , Mycobacterium tuberculosis , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Mutación , Mycobacterium tuberculosis/química , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/aislamiento & purificación , Estrés Oxidativo/genética , Compuestos de Sulfhidrilo
3.
Tuberculosis (Edinb) ; 111: 78-85, 2018 07.
Artículo en Inglés | MEDLINE | ID: mdl-30029919

RESUMEN

The emerging resistance of tuberculosis (TB) to current first line drugs (isoniazid, rifampicin, pyrazinamide, ethambutol) warrants alternative treatment approaches with broad-spectrum efficacy. Previously, we have shown that sulfamethoxazole (SMX) has synergestic activity with rifampicin against Mycobacterium tuberculosis. The primary target of SMX is folP1 in mycobacteria; however, SMX may affect other secondary targets in M. tuberculosis. This study investigated the potential additional targets of SMX in a clinical isolate of M. tuberculosis using Orbitrap mass spectrometry to identify differentially expressed proteins following treatment with a sub-lethal concentration of SMX. Raw data have been deposited as ProteomeXchange accession PXD009315. Our proteomic analysis identified approximately 1500 proteins in total of which 45 proteins were differentially regulated as a result of SMX treatment. These included 25 upregulated and 20 downregulated proteins. The oxidative stress proteins (Rv2428, AhpC and Rv2394, GgtB) and an enzyme from the electron transport chain (Ndh-II, Rv1854c) were found to be upregulated. Gene expression analysis correlated with the observed proteomic changes. In conclusion our results show that SMX treatment of a drug sensitive M. tuberculosis clinical isolate resulted in the regulation of proteins involved in the oxidative stress response, indicating the induction of oxidative stress by SMX in mycobacteria.


Asunto(s)
Antituberculosos/farmacología , Proteínas Bacterianas/metabolismo , Mycobacterium tuberculosis/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Proteómica/métodos , Sulfametoxazol/farmacología , Proteínas Bacterianas/genética , Cromatografía de Fase Inversa , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/metabolismo , Espectrometría de Masas en Tándem
4.
J Biomed Sci ; 25(1): 55, 2018 Jul 12.
Artículo en Inglés | MEDLINE | ID: mdl-30001196

RESUMEN

BACKGROUND: Three low molecular weight thiols are synthesized by Mycobacterium tuberculosis (M.tb), namely ergothioneine (ERG), mycothiol (MSH) and gamma-glutamylcysteine (GGC). They are able to counteract reactive oxygen species (ROS) and/or reactive nitrogen species (RNS). In addition, the production of ERG is elevated in the MSH-deficient M.tb mutant, while the production of MSH is elevated in the ERG-deficient mutants. Furthermore, the production of GGC is elevated in the MSH-deficient mutant and the ERG-deficient mutants. The propensity of one thiol to be elevated in the absence of the other prompted further investigations into their interplay in M.tb. METHODS: To achieve that, we generated two M.tb mutants that are unable to produce ERG nor MSH but are able to produce a moderate (ΔegtD-mshA) or significantly high (ΔegtB-mshA) amount of GGC relative to the wild-type strain. In addition, we generated an M.tb mutant that is unable to produce GGC nor MSH but is able to produce a significantly low level of ERG (ΔegtA-mshA) relative to the wild-type strain. The susceptibilities of these mutants to various in vitro and ex vivo stress conditions were investigated and compared. RESULTS: The ΔegtA-mshA mutant was the most susceptible to cellular stress relative to its parent single mutant strains (ΔegtA and ∆mshA) and the other double mutants. In addition, it displayed a growth-defect in vitro, in mouse and human macrophages suggesting; that the complete inhibition of ERG, MSH and GGC biosynthesis is deleterious for the growth of M.tb. CONCLUSIONS: This study indicates that ERG, MSH and GGC are able to compensate for each other to maximize the protection and ensure the fitness of M.tb. This study therefore suggests that the most effective strategy to target thiol biosynthesis for anti-tuberculosis drug development would be the simultaneous inhibition of the biosynthesis of ERG, MSH and GGC.


Asunto(s)
Cisteína/biosíntesis , Dipéptidos/biosíntesis , Ergotioneína/biosíntesis , Glicopéptidos/biosíntesis , Inositol/biosíntesis , Tuberculosis/microbiología , Animales , Cisteína/antagonistas & inhibidores , Cisteína/genética , Dipéptidos/antagonistas & inhibidores , Dipéptidos/genética , Ergotioneína/antagonistas & inhibidores , Ergotioneína/genética , Glicopéptidos/antagonistas & inhibidores , Glicopéptidos/genética , Humanos , Inositol/antagonistas & inhibidores , Inositol/genética , Ratones , Peso Molecular , Mycobacterium tuberculosis/efectos de los fármacos , Mycobacterium tuberculosis/patogenicidad , Estrés Oxidativo , Especies de Nitrógeno Reactivo/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Compuestos de Sulfhidrilo/química , Compuestos de Sulfhidrilo/metabolismo , Tuberculosis/tratamiento farmacológico , Tuberculosis/genética , Tuberculosis/patología
5.
Artículo en Inglés | MEDLINE | ID: mdl-29437626

RESUMEN

The high acquisition rate of drug resistance by Mycobacterium tuberculosis necessitates the ongoing search for new drugs to be incorporated in the tuberculosis (TB) regimen. Compounds used for the treatment of other diseases have the potential to be repurposed for the treatment of TB. In this study, a high-throughput screening of compounds against thiol-deficient Mycobacterium smegmatis strains and subsequent validation with thiol-deficient M. tuberculosis strains revealed that ΔegtA and ΔmshA mutants had increased susceptibility to azaguanine (Aza) and sulfaguanidine (Su); ΔegtB and ΔegtE mutants had increased susceptibility to bacitracin (Ba); and ΔegtA, ΔmshA, and ΔegtB mutants had increased susceptibility to fusaric acid (Fu). Further analyses revealed that some of these compounds were able to modulate the levels of thiols and oxidative stress in M. tuberculosis This study reports the activities of Aza, Su, Fu, and Ba against M. tuberculosis and provides a rationale for further investigations.


Asunto(s)
Antituberculosos/farmacología , Mycobacterium tuberculosis/efectos de los fármacos , Azaguanina/farmacología , Mutación/genética , Mycobacterium tuberculosis/genética , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/genética , Sulfaguanidina/farmacología , Compuestos de Sulfhidrilo/metabolismo
6.
Biochem Biophys Res Commun ; 495(1): 174-178, 2018 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-29101028

RESUMEN

Mycobacterium tuberculosis (M.tb.), the causative agent of tuberculosis (TB), cannot synthesize GSH, but synthesizes two major low molecular weight thiols namely mycothiol (MSH) and ergothioneine (ERG). Gamma-glutamylcysteine (GGC), an intermediate in GSH synthesis, has been implicated in the protection of lactic acid bacteria from oxidative stress in the absence of GSH. In mycobacteria, GGC is an intermediate in ERG biosynthesis, and its formation is catalysed by EgtA (GshA). GGC is subsequently used by EgtB in the formation of hercynine-sulphoxide-GGC. In this study, M.tb. mutants harbouring unmarked, in-frame deletions in each of the fives genes involved in ERG biosynthesis (egtA, egtB, egtC, egtD and egtE) or a marked deletion of the mshA gene (required for MSH biosynthesis) were generated. Liquid chromatography tandem mass spectrometry analyses (LC-MS) revealed that the production of GGC was elevated in the MSH-deficient and the ERG-deficient mutants. The ERG-deficient ΔegtB mutant which accumulated GGC was more resistant to oxidative and nitrosative stress than the ERG-deficient, GGC-deficient ΔegtA mutant. This implicates GGC in the detoxification of reactive oxygen and nitrogen species in M.tb.


Asunto(s)
Dipéptidos/metabolismo , Ergotioneína/genética , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/metabolismo , Estrés Nitrosativo , Estrés Oxidativo , Vías Biosintéticas , Cisteína/genética , Cisteína/metabolismo , Dipéptidos/genética , Ergotioneína/metabolismo , Eliminación de Gen , Glicopéptidos/genética , Glicopéptidos/metabolismo , Humanos , Inositol/genética , Inositol/metabolismo , Tuberculosis/microbiología
7.
PLoS One ; 12(10): e0185068, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28972974

RESUMEN

Glutamine synthetase is a ubiquitous central enzyme in nitrogen metabolism that is controlled by up to four regulatory mechanisms, including adenylylation of some or all of the twelve subunits by adenylyl transferase. It is considered a potential therapeutic target for the treatment of tuberculosis, being essential for the growth of Mycobacterium tuberculosis, and is found extracellularly only in the pathogenic Mycobacterium strains. Human glutamine synthetase is not regulated by the adenylylation mechanism, so the adenylylated form of bacterial glutamine synthetase is of particular interest. Previously published reports show that, when M. tuberculosis glutamine synthetase is expressed in Escherichia coli, the E. coli adenylyl transferase does not optimally adenylylate the M. tuberculosis glutamine synthetase. Here, we demonstrate the production of soluble adenylylated M. tuberulosis glutamine synthetase in E. coli by the co-expression of M. tuberculosis glutamine synthetase and M. tuberculosis adenylyl transferase. The differential inhibition of adenylylated M. tuberulosis glutamine synthetase and deadenylylated M. tuberulosis glutamine synthetase by ATP based scaffold inhibitors are reported. Compounds selected on the basis of their enzyme inhibition were also shown to inhibit M. tuberculosis in the BACTEC 460TB™ assay as well as the intracellular inhibition of M. tuberculosis in a mouse bone-marrow derived macrophage assay.


Asunto(s)
Adenosina Monofosfato/metabolismo , Descubrimiento de Drogas , Glutamato-Amoníaco Ligasa/antagonistas & inhibidores , Mycobacterium tuberculosis/enzimología , Animales , Antituberculosos/farmacología , Relación Dosis-Respuesta a Droga , Glutamato-Amoníaco Ligasa/metabolismo , Células HeLa , Humanos , Ratones , Pruebas de Sensibilidad Microbiana , Mycobacterium tuberculosis/efectos de los fármacos
8.
Tuberculosis (Edinb) ; 100: 53-60, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27553410

RESUMEN

The culturing of mycobacteria is a standard procedure that is consistent world-wide, with little variation in the growth media constituents, particularly those found in liquid and solid media. Before the 1940s however, the aggregating nature of mycobacteria as well as the characteristic slow growth-rate saw mycobacterial research delay considerably. Dubos and colleagues addressed both these issues and observed that a very small volume of Tween detergent was sufficient to greatly improve the culturing of mycobacteria. Over the years however, evidence of the unfavourable effects of this detergent on a number of morphological, biochemical, pathogenic and host-interacting properties of mycobacteria surfaced. For the first time we bring together literature, past and present to comprehensively review the mycobacterial properties which are, and are not affected by the use of this detergent. We also address other detergents and methods which may circumvent the need to include Tween compounds in mycobacterial culture media.


Asunto(s)
Mycobacterium/patogenicidad , Técnicas Bacteriológicas/métodos , Pared Celular/efectos de los fármacos , Medios de Cultivo , Detergentes/farmacología , Interacciones Huésped-Patógeno/efectos de los fármacos , Humanos , Pruebas de Sensibilidad Microbiana/métodos , Mycobacterium/efectos de los fármacos , Mycobacterium/crecimiento & desarrollo , Virulencia/efectos de los fármacos
9.
Int J Food Microbiol ; 217: 170-6, 2016 Jan 18.
Artículo en Inglés | MEDLINE | ID: mdl-26544204

RESUMEN

Mycobacterium bovis that causes Bovine tuberculosis (BTB) can be transmitted to humans thought consumption of raw and raw fermented milk products from diseased animals. Lactic acid bacteria (LAB) used in popular traditional milk products in Africa produce anti-microbial compounds that inhibit some pathogenic and spoilage bacteria. M. bovis BCG is an attenuated non-pathogenic vaccine strain of M. bovis and the aim of the study was to determine the effect of the fermentation process on the survival of M. bovis BCG in milk. M. bovis BCG at concentrations of 6 log CFU/ml was added to products of kefir fermentation. The survival of M. bovis BCG was monitored at 12-h intervals for 72 h by enumerating viable cells on Middlebrook 7H10 agar plates enriched with 2% BD BACTEC PANTA™. M. bovis BCG was increasingly reduced in sterile kefir that was fermented for a period of 24h and longer. In the milk fermented with kefir grains, Lactobacillus paracasei subsp. paracasei or Lactobacillus casei, the viability of M. bovis BCG was reduced by 0.4 logs after 24h and by 2 logs after 48 h of fermentation. No viable M. bovis BCG was detected after 60 h of fermentation. Results from this study show that long term fermentation under certain conditions may have the potential to inactivate M. bovis BCG present in the milk. However, to ensure safety of fermented milk in Africa, fermentation should be combined with other hurdle technologies such as boiling and milk pasteurisation.


Asunto(s)
Productos Lácteos Cultivados/microbiología , Fermentación/fisiología , Contaminación de Alimentos , Lactobacillaceae/metabolismo , Mycobacterium bovis/crecimiento & desarrollo , África , Animales , Antibiosis , Bovinos , Humanos , Ácido Láctico/metabolismo
10.
Benef Microbes ; 5(3): 351-66, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24463204

RESUMEN

Many lactic acid bacteria produce bacteriocins with a rather broad spectrum of inhibition, which could offer potential applications in food preservation. Bacteriocin production by starter cultures may bring advantage to these strains in competitive interactions with pathogenic bacteria from the food matrix. The objective of this study was to determine the safety of beneficial strains (Lactobacillus plantarum ST202Ch and ST216Ch, Enterococcus faecium ST211Ch, and Lactobacillus sakei ST22Ch, ST153Ch and ST154Ch) previously isolated from fermented meat products and characterised as bacteriocin producers. Auto-aggregation was strain-specific, and values of 28.97, 27.86 and 28.56% were recorded for L. sakei ST22Ch, ST153Ch and ST154Ch, respectively, 16.95 and 14.58% for L. plantarum ST202Ch and ST216Ch, respectively, and 12.77% for E. faecium ST211Ch. Various degrees of co-aggregation between 28.85 and 44.76% for Listeria monocytogenes 211 and 409, and between 23.60 to 34.96% for E. faecium ATCC 19443 were observed. According to the results of the diffusion method, the studied strains demonstrated susceptibility to penicillin G, ampicillin, amoxicillin, amoxicillin/clavulonic acid, imipenem, linezolid, and tetracycline. In addition, the susceptibility of the six strains to various non-antibiotic commercial drugs was examined. Production of ß-galactosidase by L. sakei ST22Ch, ST153Ch and ST154Ch, L. plantarum ST202Ch and ST216Ch, and E. faecium ST211Ch was confirmed by employing sterile filter paper discs impregnated with o-nitrophenyl-ß-D-galactopyranose. A statistically significant (P<0.001) inhibition of Mycobacterium tuberculosis growth by bacteriocins produced by L. plantarum ST202Ch (38.3%) and ST216Ch (48.6%), L. sakei ST153Ch (16.2%) and ST154Ch (16.1%), and E. faecium ST211Ch (21.7%) was observed. As determined by the polymerase chain reaction, the tested strains showed a low virulence gene profile.


Asunto(s)
Bacteriocinas/farmacología , Lactobacillus/clasificación , Productos de la Carne/microbiología , Mycobacterium tuberculosis/crecimiento & desarrollo , Probióticos/farmacología , Antibacterianos , Bacteriocinas/biosíntesis , Reactores Biológicos , Farmacorresistencia Bacteriana , Enterococcus faecium/efectos de los fármacos , Fermentación/fisiología , Microbiología de Alimentos , Lactobacillus/aislamiento & purificación , Lactobacillus/patogenicidad , Lactobacillus plantarum/efectos de los fármacos , Listeria monocytogenes/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Mycobacterium tuberculosis/efectos de los fármacos , Portugal , Probióticos/efectos adversos , beta-Galactosidasa/metabolismo
11.
J Hosp Infect ; 68(1): 45-51, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18069086

RESUMEN

Clinical isolates of meticillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, Candida albicans and Mycobacterium tuberculosis (MTB) were tested against copper (Cu) and its alloys. Stainless steel and polyvinylchloride (PVC) were used as controls. The amount of Cu required to inhibit test isolates at room temperature (24 degrees C) and at 4 degrees C was determined. At room temperature, Cu, DZR Brass (Cu 62%, Pb 2.5%, arsenate 0.13% and Zn 22.5%) and Brass 70/30 (Cu 70% and zinc 30%) inhibited C. albicans and K. pneumoniae at 60 min; nickel silver (NiAg) inhibited C. albicans at 60 min and K. pneumoniae at 270 min. P. aeruginosa was inhibited by Brass 70/30 and nickel silver (NiAg) at 180 min and at 270 min by Cu and DZR. Cu and DZR inhibited A. baumannii at 180 min while the other alloys were effective at 360 min. Stainless steel and PVC showed little or no inhibitory activity. Two M. tuberculosis strains, one isoniazid resistant (R267) and the other multidrug resistant (R432), demonstrated growth inhibition with Cu of 98% and 88% respectively compared with PVC; the other alloys were less active. Time to positivity (TTP) for R267 was >15 days with Cu and 11 days for the other alloys; with R432 it was 5 days. Effective inhibition of nosocomial pathogens and MTB by Cu and alloys was best when the Cu content was >55%.


Asunto(s)
Aleaciones/farmacología , Cobre/farmacología , Infección Hospitalaria/prevención & control , Contaminación de Equipos/prevención & control , Mycobacterium tuberculosis/efectos de los fármacos , Acinetobacter baumannii/efectos de los fármacos , Farmacorresistencia Fúngica , Farmacorresistencia Bacteriana Múltiple , Fómites/microbiología , Humanos , Klebsiella pneumoniae/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Pseudomonas aeruginosa/efectos de los fármacos , Sudáfrica , Staphylococcus aureus/efectos de los fármacos
12.
J Appl Microbiol ; 104(2): 465-77, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17922827

RESUMEN

AIMS: To evaluate the probiotic properties of strains isolated from boza, a traditional beverage produced from cereals. METHODS AND RESULTS: The strains survived low pH conditions (pH 3.0), grew well at pH 9.0 and were not inhibited by the presence of 0.3% (w/v) oxbile. Cytotoxicity levels of the bacteriocins, expressed as CC(50), ranged from 38 to 3776 microg ml(-1). Bacteriocin bacST284BZ revealed high activity (EC(50) = 735 microg ml(-1)) against herpes simplex virus type 1. Growth of Mycobacterium tuberculosis was 69% repressed after 5 days in the presence of bacST194BZ. Various levels of auto-cell aggregation and co-aggregation with Listeria innocua LMG 13568 were observed. Adhesion of the probiotic strains to HT-29 cells ranged from 18 to 22%. CONCLUSIONS: Boza is a rich source of probiotic lactic acid bacteria. All strains survived conditions simulating the gastrointestinal tract and produced bacteriocins active against a number of pathogens. Adherence to HT-29 and Caco-2 cells was within the range reported for Lactobacillus rhamnosus GG, a well-known probiotic. In addition, the high hydrophobicity readings recorded define the strains as good probiotics. SIGNIFICANCE AND IMPACT OF THE STUDY: Boza contains a number of different probiotic lactic acid bacteria and could be marketed as a functional food product.


Asunto(s)
Grano Comestible , Microbiología de Alimentos , Lactobacillaceae/aislamiento & purificación , Probióticos , Antibiosis , Adhesión Bacteriana , Bacteriocinas/análisis , Bacteriocinas/aislamiento & purificación , Bebidas , Células CACO-2 , Células HT29 , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Lactobacillaceae/fisiología , Mycobacterium tuberculosis
13.
IUBMB Life ; 56(2): 101-6, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15085934

RESUMEN

In tuberculosis, oxidative stress is a result of tissue inflammation, poor dietary intake of micronutrients due to illness, free radical burst from activated macrophages, and anti-tuberculosis drugs. These free radicals may in turn contribute towards pulmonary inflammation if not neutralized by antioxidants. The total antioxidant status (TAS) of individuals is a function of dietary, enzymatic, and other systemic antioxidants and is therefore an indicator of the free radical load. Our aim was to evaluate the TAS of healthy and M. tuberculosis-infected persons from a high TB incidence community, as well as tuberculosis patients at various stages of antituberculosis drug treatment and to correlate results with plasma micronutrient levels. Blood plasma samples from TB infected patients and following antituberculosis drug treatment were assayed for TAS, vitamins A, E and Zinc. Statistical analysis of results was by one-way ANOVA and the Tukey multiple comparison post test. Active TB patients showed a significantly lower TAS (P < 0.001) compared to the community controls. We also show that TAS values increase during therapy. Results correlated with micronutrients vitamin A and zinc but vitamin E remained unaffected. We suggest that total antioxidant status of TB patients should be considered for more effective disease control and that diets low in antioxidants may render individuals susceptible to tuberculosis.


Asunto(s)
Antioxidantes/metabolismo , Estrés Oxidativo/efectos de los fármacos , Tuberculosis Pulmonar/metabolismo , Antituberculosos/farmacología , Humanos , Tuberculosis Pulmonar/tratamiento farmacológico
14.
Tuberculosis (Edinb) ; 82(2-3): 45-53, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12356454

RESUMEN

SETTING: DNA repair genes assist the organism in maintaining DNA integrity in the face of environmental (mutagenic) stress. The genome sequences of M. tuberculosis and M. bovis demonstrate sequences suggestive of an O(6)-alkylguanine-DNA alkyltransferase DNA repair activity similar to that seen in almost all other bacterial and eukaryotic organisms. The near ubiquitousness of this gene implies an important function. OBJECTIVE: Our aim was to ascertain whether mycobacteria exert an alkyltransferase response to mutagen (streptozotocin) stimulation and whether alkyltransferase activity is essential for mycobacterial survival. DESIGN: Alkyltransferase activity in slow- and fast-growing mycobacterial species was determined in the presence and absence of sublethal concentrations of an alkylating agent streptozotocin. The intracellular survival and response to anti-tuberculosis drugs of an alkyltransferase knockout strain of M. bovis BCG was also determined. RESULTS: We demonstrate the presence of O(6)-alkylguanine alkyltransferase (cellular methyltransferase activity) in mycobacterial species and that there is an inducible and constitutive form in fast-growing mycobacteria (M. smegmatis), whereas only the constitutive form exists in the pathogenic or slow-growing species (M. bovis BCG) under the conditions tested. The overall activity of the constitutive form is high. We also show that intracellular growth of M. bovis BCG in macrophages is reduced when the alkyltransferase gene is absent. The presence of alkyltransferase activity appears to assist the organism in reducing the effects of isoniazid, since interruption of the gene confers sensitivity to the drug. CONCLUSIONS: We conclude that for the slow-growing mycobacteria, an inducible response is not essential as their ecological niche is stable and protected, but that the presence of the alkyltransferase activity confers a growth advantage in macrophages and offers some protection against antibiotics.


Asunto(s)
Reparación del ADN/genética , Mycobacterium bovis/enzimología , Mycobacterium smegmatis/enzimología , Mycobacterium tuberculosis/enzimología , O(6)-Metilguanina-ADN Metiltransferasa/metabolismo , Secuencia de Bases , Southern Blotting , Activación Enzimática , Humanos , Macrófagos/microbiología , Metiltransferasas/genética , Mycobacterium bovis/genética , Mycobacterium smegmatis/genética , Mycobacterium tuberculosis/genética , O(6)-Metilguanina-ADN Metiltransferasa/genética , Especificidad de la Especie
15.
Antimicrob Agents Chemother ; 43(4): 975-7, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10103215

RESUMEN

The limited number of effective antituberculosis drugs available necessitates optimizing current treatments. We show that melatonin, which is synthesized in the pineal gland, can cause at least a threefold increase in the efficacy of isoniazid. This suggests that tuberculosis chemotherapy can be improved by innate molecules such as melatonin.


Asunto(s)
Antioxidantes/farmacología , Antituberculosos/farmacología , Isoniazida/farmacología , Melatonina/farmacología , Mycobacterium tuberculosis/efectos de los fármacos , Resistencia a Múltiples Medicamentos , Sinergismo Farmacológico , Humanos , Pruebas de Sensibilidad Microbiana , Mycobacterium tuberculosis/citología
16.
J Clin Microbiol ; 35(6): 1545-9, 1997 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9163479

RESUMEN

Analysis of restriction fragment length polymorphisms in the genome of Mycobacterium tuberculosis (DNA fingerprinting) has proved to be a useful epidemiological tool in the study of tuberculosis within populations or communities. However, to date, no similar method has been developed to study the epidemiology of nontuberculous mycobacteria (NTM). In this communication, we report that a simple oligonucleotide repeat, (GTG)5, can be used to accurately genotype all species and strains of NTM tested. We suggest that this technology is an easily applied and accurate tool which can be used for the study of the epidemiology of NTM.


Asunto(s)
Dermatoglifia del ADN/métodos , Mycobacterium/genética , Oligodesoxirribonucleótidos , Polimorfismo de Longitud del Fragmento de Restricción , ADN Bacteriano/análisis , Desoxirribonucleasas de Localización Especificada Tipo II , Humanos , Mycobacterium/clasificación , Infecciones por Mycobacterium/epidemiología , Infecciones por Mycobacterium/microbiología , Reproducibilidad de los Resultados
17.
Br J Cancer ; 70(2): 195-8, 1994 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8054265

RESUMEN

The establishment of a new prostate cell line (BM1604) from a human prostatic adenocarcinoma is reported. The line was rapidly established by culture of tissue on an extracellular matrix, previously laid down by culture of non-related cells. The method has been shown to work well, and other prostate lines have recently been cultured in this way. The cells have a doubling time of 28 h. DNA fingerprinting comparison of the genome from the tumour, the germline and the cells shows that somatic mutations have occurred in the tumour and that clonal selection has clearly occurred in establishment of the line. Many somatic mutations are apparent in the selected cells, which are now stable in culture. This method and the cells may be a useful addition to the limited material available for the in vitro study of prostate cells.


Asunto(s)
Adenocarcinoma/genética , Adenocarcinoma/patología , Dermatoglifia del ADN , Neoplasias de la Próstata/genética , Neoplasias de la Próstata/patología , Células Tumorales Cultivadas , Anciano , ADN/análisis , ADN de Neoplasias/análisis , Humanos , Inmunohistoquímica , Leucocitos/química , Masculino
18.
J Clin Microbiol ; 32(5): 1318-21, 1994 May.
Artículo en Inglés | MEDLINE | ID: mdl-7914207

RESUMEN

Culture of Mycobacterium tuberculosis provides no information on the identity of a strain or the distribution of such a strain in the community. Strain identification of M. tuberculosis can help to address important epidemiological questions, e.g., the origin of an infection in a patient's household or community, whether reactivation of infection is endogenous or exogenous in origin, and the spread and early detection of organisms with acquired antibiotic resistance. To research this problem, strain identification must be reliable and accurate. Although genetic identification techniques already exist, it is valuable to have genetic identification techniques based on a number of genetic markers to improve the accurate identification of M. tuberculosis strains. We show that oligonucleotide (GTG)5 can be successfully applied to the identification of M. tuberculosis strains. This technique may be particularly useful in cases in which M. tuberculosis strains have few or no insertion elements (e.g., IS6110) or in identifying other strains of mycobacteria when informative probes are lacking.


Asunto(s)
Sondas de ADN/genética , ADN Bacteriano/genética , Mycobacterium tuberculosis/genética , Secuencias Repetitivas de Ácidos Nucleicos , Adulto , Técnicas de Tipificación Bacteriana , Secuencia de Bases , Niño , Dermatoglifia del ADN , Elementos Transponibles de ADN , Estudios de Evaluación como Asunto , Femenino , Marcadores Genéticos , Humanos , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Mycobacterium tuberculosis/clasificación , Mycobacterium tuberculosis/aislamiento & purificación , Polimorfismo de Longitud del Fragmento de Restricción , Sudáfrica/epidemiología , Especificidad de la Especie , Tuberculosis Pulmonar/epidemiología , Tuberculosis Pulmonar/microbiología
20.
Anticancer Res ; 10(3): 833-6, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2369096

RESUMEN

One hundred and seventy-eight patients at risk for gastric carcinoma had upper gastrointestinal endoscopy. Twenty-seven selected patients with the type B of chronic atrophic gastritis, 32 patients with normal mucosa and 47 non-scoped healthy controls were tested for plasma vitamin C, retinol and tocopherol. The total vitamin C level was also assessed in gastric juice of scoped patients. Micronutrient levels were related to gastric pH, nitrites and gastric mucosal pathology. The study showed a higher level of pH (greater than 4) and high nitrites in gastric juice in patients with chronic atrophic gastritis, gastric malignant and dysplastic lesions. Neither the hypochlorhydria nor gastric nitrites affected the prevalence of C. pylori in gastric mucosa. Low gastric and plasma concentrations of vitamin C observed in patients with chronic atrophic gastritis showed an inverted relationship with pH level, and an inter-relationship of other vitamins with antioxidant properties (vitamins A and E).


Asunto(s)
Jugo Gástrico/análisis , Gastritis Atrófica/fisiopatología , Gastritis/fisiopatología , Nitritos/análisis , Neoplasias Gástricas/etiología , Vitaminas/análisis , Ácido Ascórbico/análisis , Ácido Ascórbico/sangre , Endoscopía , Femenino , Determinación de la Acidez Gástrica , Mucosa Gástrica/patología , Gastritis Atrófica/patología , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/patología , Úlcera Gástrica/patología , Úlcera Gástrica/fisiopatología , Vitamina A/sangre , Vitamina E/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...